Loading company details...
Beta
Latest Form 4 (Oct 15, 2026): Gwenn Hansen (Chief Scientific Officer): Exercise/Conversion of 1,452 shares, $2.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Gwenn Hansen, Chief Scientific Officer | Exercise/Conversion | 1,452 | $2.7K |
| Oct 14, 2026 | Julia P. Gregory | Exercise/Conversion | 22,583 | $42.0K |
| Oct 2, 2026 | Christine Ring, Chief Legal Officer | Exercise/Conversion | 5,786 | $50.5K |
| Sep 2, 2026 | Christine Ring, Chief Legal Officer | Exercise/Conversion | 5,787 | $50.5K |
| Sep 1, 2026 | Gwenn Hansen, Chief Scientific Officer | Exercise/Conversion | 1,452 | $2.7K |
| Aug 5, 2026 | Gwenn Hansen, Chief Scientific Officer | Exercise/Conversion | 4,356 | $8.1K |
| Aug 5, 2026 | Gwenn Hansen, Chief Scientific Officer | Sale | 1,500 | $35.8K |
| Aug 5, 2026 | Houte Hans Van, Chief Financial Officer | Sale | 1,794 | $42.9K |
| Aug 3, 2026 | Christine Ring, Chief Legal Officer | Exercise/Conversion | 5,787 | $50.5K |
| Jul 30, 2026 | Houte Hans Van, Chief Financial Officer | Exercise/Conversion | 3,750 | n/a |